Skip to main content
SpringerLink
Log in

WHI estrogen plus progestin trial a good return on investment

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The analysis was from a payer perspective.

  2. National Heart, Lung and Blood Institute in Bethesda (MD, USA)

References

  1. Roth JA, et al. Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study. Annals of Internal Medicine 160: 594-602, No. 9, 6 May 2014.

    Article  PubMed  Google Scholar 

  2. Lauer MS. Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study. Annals of Internal Medicine 160: No. 9, 6 May 2014. Available from: URL: http://dx.doi.org/10.7326/M14-0655.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

WHI estrogen plus progestin trial a good return on investment. PharmacoEcon Outcomes News 703, 9 (2014). https://doi.org/10.1007/s40274-014-1268-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1268-2

Search

Navigation